ARCHIVES

FDA: Silicone Breast Implants Safe, But Not “Lifetime Device”

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

Community Based Control Program Taking Final Shape

April 29, 1977

Ethics rules slammed by NIH scientists, institute directors, societies, Senators.

April 8, 2005

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

NAB Report To President Makes Pitch for Money, Cites Research Progress

August 9, 1974

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014